LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL

A. J. Vallejo-Vaz; C. J. Packard; B. A. Ference; R. D. Santos; J. J. Kastelein; E. A. Stein; A. L. Catapano; T. R. Pedersen; G. F. Watts; K. K. Ray

doi:10.1016/j.atherosclerosis.2019.06.016

LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL

A. J. Vallejo-Vaz, C. J. Packard, B. A. Ference, R. D. Santos, J. J. Kastelein, E. A. Stein, A. L. Catapano, T. R. Pedersen, G. F. Watts, K. K. Ray

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	E6-E6
Number of pages	1
Journal	Atherosclerosis
Volume	287
DOIs	https://doi.org/10.1016/j.atherosclerosis.2019.06.016
Publication status	Published - Aug 2019
Event	87th Congress of the European Atherosclerosis Society (EAS) - Maastricht, Netherlands Duration: 26 May 2019 → 29 May 2019 https://eas2019.com/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosis.2019.06.016

Cite this

Vallejo-Vaz, A. J., Packard, C. J., Ference, B. A., Santos, R. D., Kastelein, J. J., Stein, E. A., Catapano, A. L., Pedersen, T. R., Watts, G. F., & Ray, K. K. (2019). LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL. Atherosclerosis, 287, E6-E6. https://doi.org/10.1016/j.atherosclerosis.2019.06.016

@article{903306f0995046748e56ef90b25a3500,

title = "LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL",

author = "Vallejo-Vaz, {A. J.} and Packard, {C. J.} and Ference, {B. A.} and Santos, {R. D.} and Kastelein, {J. J.} and Stein, {E. A.} and Catapano, {A. L.} and Pedersen, {T. R.} and Watts, {G. F.} and Ray, {K. K.}",

year = "2019",

month = aug,

doi = "10.1016/j.atherosclerosis.2019.06.016",

language = "English",

volume = "287",

pages = "E6--E6",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier",

note = "87th Congress of the European Atherosclerosis Society (EAS) ; Conference date: 26-05-2019 Through 29-05-2019",

url = "https://eas2019.com/",

}

Vallejo-Vaz, AJ, Packard, CJ, Ference, BA, Santos, RD, Kastelein, JJ, Stein, EA, Catapano, AL, Pedersen, TR, Watts, GF & Ray, KK 2019, 'LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL', Atherosclerosis, vol. 287, pp. E6-E6. https://doi.org/10.1016/j.atherosclerosis.2019.06.016

TY - JOUR

T1 - LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE

T2 - 87th Congress of the European Atherosclerosis Society (EAS)

AU - Vallejo-Vaz, A. J.

AU - Packard, C. J.

AU - Ference, B. A.

AU - Santos, R. D.

AU - Kastelein, J. J.

AU - Stein, E. A.

AU - Catapano, A. L.

AU - Pedersen, T. R.

AU - Watts, G. F.

AU - Ray, K. K.

PY - 2019/8

Y1 - 2019/8

U2 - 10.1016/j.atherosclerosis.2019.06.016

DO - 10.1016/j.atherosclerosis.2019.06.016

M3 - Abstract/Meeting Abstract

SN - 0021-9150

VL - 287

SP - E6-E6

JO - Atherosclerosis

JF - Atherosclerosis

Y2 - 26 May 2019 through 29 May 2019

ER -